Overview
Status
Active
Registry date
2014-04-04
Share capital
50 000,00 PLN
Registered address
Nowogrodzka 200, 18-400 Łomża, Poland
Electronic delivery address
AE:PL-34201-97193-WSRGS-29
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 52 days early.
- 2025filed
- 202417/06/2025
- 202316/05/2024
- 202212/07/2023
- 202108/06/2022
- 202007/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.41mMedianUSD 66.63kAverageUSD 1.19m
Net profit
This companyUSD 2.97kMedianUSD 1.80kAverageUSD 66.86k
Operating costs
This companyUSD 3.32mMedianUSD 50.36kAverageUSD 1.01m
Assets
This companyUSD 1.81mMedianUSD 69.63kAverageUSD 2.60m
Industry
Trademarks
Multi-Pharm currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2016.
| Mark | Protected until | |
|---|---|---|
| essentliver(word) | – |
Authorized Representatives
Marcin Piechocki – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Cezary Leszek Jezierskiage 62 | 900 | $12,155.59 | 90% |
Marcin Piechockiage 51 | 100 | $1,350.62 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-04-16.
87 1160 2202 0000 0003 5146 7680
28 1160 2202 0000 0002 7295 1122
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $49,170.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,025$3,025 | Prezes Banku Gospodarstwa Krajowego | |
| Feb 16, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,412$5,412 | Prezes Banku Gospodarstwa Krajowego | |
| Feb 23, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,808$3,808 | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| LemontreeS.A. | $3,079,014.14 | lemontree.realestate | ||
| Tomas Consultingsp. z o.o. | $1,214,137.86 | tomasconsulting.com | ||
| DCsp. z o.o. | $767,467.99 | dc.info.pl | ||
| MIR Consulting sp. z o.o.sp. k. | $221,121.75 | mir-consulting.pl | ||
| Dbajodane.Plsp. z o.o. | $191,788.70 | dbajodane.pl | ||
| Consuo-Techsp. z o.o. | $143,947.82 | consuo-tech.pl | ||
| Ndts Consultingsp. z o.o. | $65,445.03 | ndts.pl | ||
| MIR Consultingsp. z o.o. | $34,575.30 | mir-consulting.pl | ||
| Broker BusinessS.K.A. | $0.00 | brokerbusiness.eu | ||
| Rach-Mistrzsp. z o.o. | – | rach-mistrz.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-10-18 | PKD change (Removed: 20.13.Z, 20.14.Z, 20.41.Z, 20.42.Z, 20.53.Z, 20.59.Z, 21.10.Z, 21.20.Z, 32.50.Z, 46.17.Z, 46.45.Z, 46.46.Z, 46.49.Z, 46.75.Z, 46.76.Z, 46.90.Z, 47.73.Z, 47.74.Z, 47.75.Z, 52.10.B, 52.21.Z, 52.24.C, 58.13.Z, 58.19.Z, 62.01.Z, 63.11.Z, 63.12.Z, 69.20.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.10.Z, 74.20.Z, 74.30.Z, 74.90.Z, 78.10.Z, 81.21.Z, 81.22.Z, 81.29.Z, 86.90.E) | |
| 2014-04-04 | Entered in the register |
FAQ
The main business activity of Multi-Pharm focuses on business and other management consultancy activities.
The company was registered in the Polish National Court Register (KRS) on April 4, 2014.
The headquarters is located at: Nowogrodzka 200, 18-400 Łomża.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $3,077,075 in 2024, which is an increase of 1.0% compared to 2023.
Yes, the company recorded a net profit of $71,595 in 2024, meaning the company decreased its profit by 61.6%.
The largest operating cost category falls under external services. This category amounted to $2,193,551 in 2024, representing 74% of all operating expenses.
Last updated: 2026-04-07